+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Kidney Cancer Treatment Drugs Markets in China

  • PDF Icon

    Report

  • 244 Pages
  • September 2023
  • Region: China
  • AMID Co
  • ID: 1195412

China's demand for Kidney Cancer Treatment Drugs will continue to grow at 8% by 2032

China's demand for Kidney Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

Table of Contents

I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
II. BUSINESS ENVIRONMENT
  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties
III. KIDNEY CANCER TREATMENT DRUGS INDUSTRY
  • ASSESSMENTS
  • Kidney Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Driver
  • Kidney Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producer Sales Volume and Market Share
  • Alkylating Agents
  • Antimetabolites
  • Anti-Tumor Antibiotics
  • Steroids
  • Cytokines
  • Cancer Vaccines
  • Monoclonal Antibody
  • Small Molecules Drug
  • Growth Factor Inhibitors
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development
IV. KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • Overview
  • Sales Volume of Kidney Cancer Treatment Drugs by Region
  • Kidney Cancer Treatment Drugs Sales Volume
  • Chemotherapy Drugs Sales Volume
  • Alkylating Agents
  • Antimetabolites
  • Anti-Tumor Antibiotics
  • Steroids
  • Immunotherapy Drugs Sales Volume
  • Cytokines
  • Cancer Vaccines
  • Targeted Therapy Drugs Sales Volume
  • Monoclonal Antibody
  • Small Molecules Drug
  • Growth Factor Inhibitors
  • Kidney Cancer Treatment Drugs Imports and Exports
  • Kidney Cancer Treatment Drugs Imports
  • Kidney Cancer Treatment Drugs Exports
  • Pricing Trend
V. KIDNEY CANCER TREATMENT DRUGS MARKET OUTLOOK
  • Kidney Cancer Treatment Drugs Market Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits
VI. MARKETING STRATEGIES
  • China Market Entry Overview
  • China’s Distribution System
  • Kidney Cancer Treatment Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China’s Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprise
VII. KIDNEY CANCER TREATMENT DRUGS PRODUCER DIRECTORY
  • Kidney Cancer Treatment Drugs Producer Profiles and Directory
  • Major End-Users
LIST OF TABLES
I. INTRODUCTION
  • Economic Outlook Summary
II. BUSINESS ENVIRONMENT
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
III. KIDNEY CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • Kidney Cancer Treatment Drugs Sales Volume and Market Share by Drugs Classification
  • Kidney Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Location
  • Major Kidney Cancer Treatment Drugs Producer Sales Volume
  • Major Foreign Investment in China
IV. KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • Kidney Cancer Treatment Drugs Sales Volume
  • Demand of Kidney Cancer Treatment Drugs by Region
  • Chemotherapy Drugs Sales Volume and Market Share by Drugs Classification
  • Alkylating Agents Sales Volume
  • Alkylating Agents Major Producer and Their Market Share
  • Antimetabolites Sales Volume
  • Antimetabolites Major Producer and Their Market Share
  • Anti-Tumor Antibiotics Sales Volume
  • Anti-Tumor Antibiotics Major Producer and Their Market Share
  • Steroids Sales Volume
  • Steroids Major Producer and Their Market Share
  • Immunotherapy Drugs Sales Volume and Market Share by Drugs Classification
  • Cytokines Sales Volume
  • Cytokines Major Producer and Their Market Share
  • Cancer Vaccines Sales Volume
  • Cancer Vaccines Major Producer and Their Market Share
  • Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Monoclonal Antibody Sales Volume
  • Monoclonal Antibody Major Producer and Their Market Share
  • Small Molecules Drug Sales Volume
  • Small Molecules Drug Major Producer and Their Market Share
  • Growth Factor Inhibitors Sales Volume
  • Growth Factor Inhibitors Major Producer and Their Market Share
  • China’s Kidney Cancer Treatment Drugs Imports and Exports
V. KIDNEY CANCER TREATMENT DRUGS MARKET OUTLOOK
  • Kidney Cancer Treatment Drugs Sales Volume
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION
  • China’s Kidney Cancer Treatment Drugs Sales Volume
II. BUSINESS ENVIRONMENT
  • China’s GDP and Growth Rate
  • Specialty Output by Ownership
  • China’s Imports and Exports
III. KIDNEY CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • Kidney Cancer Treatment Drugs Sales Volume by Drugs Classification
  • Kidney Cancer Treatment Drugs Sales Volume in China
IV. KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • Kidney Cancer Treatment Drugs Sales Volume in China
  • Kidney Cancer Treatment Drugs Sales Volume by Type
  • Chemotherapy Drugs Sales Volume
  • Chemotherapy Drugs Sales Volume by Drugs Classification
  • Alkylating Agents Sales Volume
  • Antimetabolites Sales Volume
  • Anti-Tumor Antibiotics Sales Volume
  • Steroids Sales Volume
  • Immunotherapy Drugs Sales Volume
  • Immunotherapy Drugs Sales Volume by Drugs Classification
  • Cytokines Sales Volume
  • Cancer Vaccines Sales Volume
  • Targeted Therapy Drug Sales Volume
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Monoclonal Antibody Sales Volume
  • Small Molecules Drug Sales Volume
  • Growth Factor Inhibitors Sales Volume
  • Total Kidney Cancer Treatment Drugs Import and Export
V. KIDNEY CANCER TREATMENT DRUGS MARKET OUTLOOK
  • Kidney Cancer Treatment Drugs Sales Volume
VI. MARKETING STRATEGIES
  • China’s Distribution Channel

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Shanghai Huachen Cancer Treatment Drugs Co., Ltd
  • Shanghai Sangon Biological Technology&Servicers Co., Ltd